Gene expression profiles and genetic damage in benzo(a)pyrene diol epoxide-exposed TK6 cells

G S Akerman1, B A Rosenzweig, O E Domon

  • 1Division of Genetic and Reproductive Toxicology, National Center for Toxicological Research, US Food and Drug Administration, 3900 NCTR Road, Jefferson, AR 72079, USA.

Mutation Research
|May 4, 2004
PubMed

Insights

This study reveals that while DNA adduct formation is a sensitive indicator of chemical damage, significant gene expression changes in TK6 cells occur at higher doses associated with toxicity and mutations. Microarray analysis helps identify molecular responses to DNA damage.

Area of Science:

  • Toxicology
  • Molecular Biology
  • Genomics

Background:

  • Microarray analysis is crucial for understanding drug/chemical effects on gene expression.
  • Comparing traditional toxicology measures with gene expression changes provides insights into cellular responses to mutagens.

Purpose of the Study:

  • To compare traditional genetic toxicology measures with gene expression alterations induced by a mutagen.
  • To investigate the relationship between DNA adduct formation, cell viability, and gene expression profiles following exposure to benzo(a)pyrene-trans-7,8-dihydrodiol-9,10-epoxide (BPDE).

Main Methods:

  • TK6 cells were exposed to varying doses of BPDE.
  • DNA adduct levels, cell viability, and mutant frequencies were quantified.
  • Gene expression profiles were analyzed using microarray analysis at 4 and 24 hours post-exposure.

Main Results:

  • DNA adducts (dG-N(2)-BPDE) increased with BPDE dose, with adduct formation being the most sensitive indicator of DNA damage.
  • Cell viability decreased at 24 hours post-exposure, indicating apoptosis.
  • Significant gene expression alterations, including upregulation of Glutathione Peroxidase and Gadd45, were observed at 4 hours, with more robust changes at 24 hours, particularly at higher BPDE doses associated with toxicity and mutations.

Conclusions:

  • Changes in gene expression profiles can identify molecular pathway effects of chemicals and provide information on responses to DNA damage.
  • DNA adduct formation is a more sensitive initial marker of DNA damage than broad gene expression changes.
  • Robust gene expression alterations correlate with cellular toxicity and mutation induction.

Related Concept Videos

Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...